Literature DB >> 74464

Inactive renin in human plasma.

F H Derkx, J M von Gool, G J Wenting, R P Verhoeven, A J Man in 't Veld, M A Schalekamp.   

Abstract

Human plasma contains renin, which is enzymatically active at neutral pH (active renin), and a non-dialysable factor, which has renin-like activity after treatment at low pH (inactive renin). In vitro activated plasma-renin and purified human renal renin showed identical enzyme-kinetic properties. Quantitative estimations of inactive renin in renal venous plasma from 5 patients with renal-artery stenosis demonstrated its release by the kidney. Acute stimulation of renin release by isoprenaline, tilting, or diazoxide in 13 normotensive individuals and in 9 patients with essential hypertension increased active plasma-renin and reduced inactive plasma-renin. Inactive plasma-renin was increased and active plasma-renin decreased during suppression of renin release by propranolol in 12 patients with essential hypertension. In 55 patients with various disorders, inactive and active plasma-renin were directly correlated. However, the concentration of inactive renin, for a given value of active renin, varied widely from patient to patient. These results indicate that so-called inactive renin is indeed physiologically related to active renin. They also suggest that inactive renin can be activated not only in vitro, but also in vivo. Different renin assays measure different relative amounts of active and inactive renin. This may call for reinterpretation of results obtained by various methods, especially in situations where changes in plasma concentrations of the two forms of renin are in opposite directions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 74464     DOI: 10.1016/s0140-6736(76)90791-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Active and inactive renin after exercise.

Authors:  M Ikeda; M Matsusaki; A Kinoshita; M Koga; M Ideishi; M Sasaguri; H Tanaka; M Shindo; K Arakawa
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

2.  Hypertension symposium: newer topics on normal and abnormal blood pressure regulatory mechanisms.

Authors:  M L Tuck; M S Golub; P Eggena; J R Sowers; M Maxwell
Journal:  West J Med       Date:  1983-08

3.  Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.

Authors:  I Gavras; H Gavras; H R Brunner; C S Liang
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

4.  Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.

Authors:  S Sonkodi; E Agabiti-Rosei; R Fraser; B J Leckie; J J Morton; A M Cumming; V P Sood; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

5.  The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise.

Authors:  P J Lijnen; A K Amery; R H Fagard; T M Reybrouck; E J Moerman; A F De Schaepdryver
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

6.  Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

Authors:  G J Wenting; A J Man in 't Veld; A J Woittiez; F Boomsma; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

7.  Extrarenal prorenin and renin in anephric patients.

Authors:  A Konrads; W Hummerich; M Vlaho; G Wambach; W Böttcher; K A Meurer
Journal:  Klin Wochenschr       Date:  1980-03-03

Review 8.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

9.  Plasma active and inactive renin in the rabbit: effect of dietary sodium depletion and repletion.

Authors:  S A Grace; K A Munday; A R Noble; H K Richards
Journal:  J Physiol       Date:  1979-07       Impact factor: 5.182

10.  Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.

Authors:  A J Man in 't Veld; I M Schicht; F H Derkx; J H de Bruyn; M A Schalekamp
Journal:  Br Med J       Date:  1980-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.